Image Description (Figure0001)
Sunitinib Malate Capsule
Product Images NDC 82293-014
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sunitinib Malate (NDC 82293-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novugen Pharma (usa) Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Figure03)
Image Description (Figure2)
This text provides data on the comparison between Sunitinib Malate and IFN-a treatments in terms of median weeks, hazard ratio, and progression-free survival probability. Sunitinib Malate showed a median of 47.3 weeks compared to IFN-a with 22.0 weeks, with a hazard ratio of 0.42. The progression-free survival probability for Sunitinib Malate ranged from 107% to 95% CI (0.32, 0.54). The results suggest a significant difference in efficacy between the two treatments.*
Image Description (Figure4)
This information provides the comparison of Sunitinib Malate and Placebo in terms of progression-free survival probability, with Sunitinib Malate showing a median survival of 10.2 months while Placebo had a median of 5.4 months. The Hazard Ratio is 0.427 with a 95% confidence interval of 0.271-0.673. The data also includes the progression-free survival probability over time for both groups, with the number of subjects at risk at various time points displayed.*
Image Description (Image001)
This text provides information about a medication with NDC number 82293-014-10. It contains 12.5 mg of sunitinib equivalent to 16.7 mg sunitinib malate. The dosage and use instructions can be found in the accompanying prescribing information. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The capsules should be dispensed in tight containers and kept out of the reach of children. The medication guide should be given to each patient. The prescription is for 28 capsules measuring 18 mm x 42 mm. The prescription is for Rx only and is associated with the company named Navugen. The text also includes a Manufacturer's License Number and mentions a barcode, expiration date, and lot number.*
Image Description (Image002)
This text provides important information about a medication with NDC 82293-015-10, containing 25 mg of sunitinib equivalent to 3.4 mg sunitinib malate. It includes dosage and usage guidelines as well as storage instructions. Additionally, it mentions the need to keep the medication out of reach of children and to dispense the accompanying Medication Guide for each patient. The medication comes in capsules, to be kept in tight containers and stored at specific temperature ranges.*
Image Description (Image003)
This text provides information about a medication containing 37.5 mg of sunitinib malate in each capsule, with dosing instructions and storage recommendations. The medication is meant to be dispensed in tight containers and a medication guide should be given to each patient. The NDC number and expiration date are included for reference.*
Image Description (Image04)
Image Description (Structure01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
